Results 1 to 10 of about 91,749 (225)
Development and Validation of a Rapid Screening Test for HTLV-I IgG Antibodies
Viruses, 2022 Initial diagnosis of human T cell lymphotropic virus (HTLV) infections is mainly based by detecting antibodies in plasma or serum using laboratory-based methods.
Bobby Brooke Herrera +2 more
doaj +2 more sources
Anti-HTLV antibody profiling reveals an antibody signature for HTLV-I-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) [PDF]
Retrovirology, 2008 Background HTLV-I is the causal agent of adult T cell leukemia (ATLL) and HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Biomarkers are needed to diagnose and/or predict patients who are at risk for HAM/TSP or ATLL.
Mahieux Renaud +10 more
doaj +2 more sources
The Lancet Regional Health. Americas, 2022 Summary: Background: Brazil is a country endemic for human T-lymphotropic virus 1 and 2 (HTLV-1 and HTLV-2), systemic mycoses such as paracoccidioidomycosis (PCM) and histoplasmosis (HP), and aspergillosis (AP). The prevalence of HTLV-1/-2 infections in
Adele Caterino-de-Araujo +3 more
doaj +1 more source
Chemiluminescence Immunoassay to Detect Anti‐HTLV‐I Antibodies [PDF]
Japanese Journal of Cancer Research, 1993 A fully automated chemiluminescence immunoassay was developed for the detection of antibodies to HTLV‐I. We used partially purified viral antigens coated on small polystyrene beads together with acridinium ester‐labeled anti‐human immunoglobulin G mouse immunoglobulin G in this method.
Kamihira, Shimeru +5 more
openaire +2 more sources
Pathogens, 2021 Background. Human T-cell lymphotropic virus type 1 (HTLV-1) is responsible for tropical spastic paraparesis and HTLV-1-associated leukemia/lymphoma. The infection is endemic in some areas of Peru, but its prevalence in the Peruvian Amazon is not well ...
José-Manuel Ramos-Rincón +10 more
doaj +1 more source
Prevalence of HTLV-I Antibody in Pulmonary Cryptococcosis.
The Tohoku Journal of Experimental Medicine, 1992 A retrospective study was done to determine the prevalence of anti-HTLV-I antibodies in patients with pulmonary cryptococcosis. None of the 19 patients with pulmonary cryptococcosis had underlying immunodeficiency. Anti-HTLV-I antibody was present in 6 (32%) of 19 patients with pulmonary cryptococcosis, a significantly higher prevalence than found in ...
KOHNO, SHIGERU +9 more
openaire +3 more sources
Revista do Instituto de Medicina Tropical de São Paulo, 2004 Serum- and/or- cerebrospinal fluid (CSF) samples obtained from 190 patients suffering from chronic, progressive neurological disease were screened for the presence of human T-cell lymphotropic viruses type I (HTLV-I) and type II (HTLV-II) antibodies over
Olinda Macêdo +5 more
doaj +1 more source
Scientific African, 2019 Introduction: Human T Cell Lymphotrophic virus (HTLV) is endemic in many regions of the world including Nigeria but not ubiquitous. It has been shown to be causally associated with T cell leukaemia and other myelopathies.
Babatunde Olusola +4 more
doaj +1 more source
Arquivos de Neuro-Psiquiatria, 1998 A case of HTLV-I/II myelopathy in which the initial complaint was erectile insufficiency (EI) is reported. The only abnormalities found on the neurological exam were discrete weakness of the psoas and increased knee jerk reflexes.
JOSÉ TEOTONIO OLIVEIRA +4 more
doaj +1 more source
The Prevalence and Significance of HTLV-I/II Seroindeterminate Western Blot Patterns
Viruses, 2011 Human T-lymphotropic virus type I (HTLV-I) infects an estimated 15–20 million persons worldwide. A number of diseases have been associated with the virus including adult T-cell leukemia (ATL), HTLV-associated myelopathy/tropical spastic paraparesis (HAM ...
Yoshimi Akahata +2 more
doaj +1 more source